AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 98 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -60.9% | 146,305 | +7.8% | 0.00% | – |
| Q2 2022 | $23,000 | -56.6% | 135,700 | +20.6% | 0.00% | – |
| Q1 2022 | $53,000 | -17.2% | 112,500 | 0.0% | 0.00% | – |
| Q4 2021 | $64,000 | -68.8% | 112,500 | -9.1% | 0.00% | – |
| Q3 2021 | $205,000 | +4.6% | 123,700 | +5.5% | 0.00% | – |
| Q2 2021 | $196,000 | -7.5% | 117,200 | -6.4% | 0.00% | -100.0% |
| Q1 2021 | $212,000 | +7.1% | 125,201 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $198,000 | +304.1% | 124,801 | +142.3% | 0.00% | – |
| Q3 2020 | $49,000 | +188.2% | 51,501 | +93.6% | 0.00% | – |
| Q2 2020 | $17,000 | -59.5% | 26,601 | -74.2% | 0.00% | – |
| Q1 2020 | $42,000 | – | 103,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |